Your browser doesn't support javascript.
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.
Rodriguez-Freixinos, Víctor; Capdevila, Jaume; Pavel, Marianne; Thawer, Alia; Baudin, Eric; O'Toole, Dermot; Herrmann, Ken; Welin, Staffan; Grozinsky-Glasberg, Simona; de Herder, Wouter W; Valle, Juan W; Herman, Jackie; Kolarova, Teodora; Bouvier, Catherine; Falconi, Massimo; Ferone, Diego; Singh, Simron.
  • Rodriguez-Freixinos V; Department of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Capdevila J; Department of Medical Oncology, Vall D'Hebron University Hospital, Vall D'Hebron Institute of Oncology (VIHO), Barcelona, Spain.
  • Pavel M; Department of Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Thawer A; Department of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France.
  • O'Toole D; Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland.
  • Herrmann K; Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Welin S; Endocrine Oncology Unit, Department of Medical Sciences, University Hospital, Uppsala, Sweden.
  • Grozinsky-Glasberg S; Neuroendocrine Tumor Unit, ENETS Center of Excellence, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • de Herder WW; Section of Endocrinology, Department of Internal Medicine, Erasmus MC Cancer Center, Erasmus MC, Rotterdam, the Netherlands.
  • Valle JW; University of Manchester & Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Herman J; Canadian Neuroendocrine Tumour Society (CNETS), Canada.
  • Kolarova T; International Neuroendocrine Cancer Alliance (INCA), Boston, MA, USA.
  • Bouvier C; International Neuroendocrine Cancer Alliance (INCA), Boston, MA, USA; Neuroendocrine Cancer United Kingdom, United Kingdom.
  • Falconi M; Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Ferone D; Department of Internal Medicine & Medical Specialties, Section of Endocrinology, University of Genova, Italy.
  • Singh S; Department of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: Simron.Singh@sunnybrook.ca.
Eur J Cancer ; 144: 200-214, 2021 02.
Article in English | MEDLINE | ID: covidwho-987581
Semantic information from SemMedBD (by NLM)
1. Neuroendocrine Tumors PROCESS_OF Patients
Subject
Neuroendocrine Tumors
Predicate
PROCESS_OF
Object
Patients
2. Neuroendocrine Tumors COEXISTS_WITH COVID-19
Subject
Neuroendocrine Tumors
Predicate
COEXISTS_WITH
Object
COVID-19
3. Neuroendocrine Tumors PROCESS_OF Patients
Subject
Neuroendocrine Tumors
Predicate
PROCESS_OF
Object
Patients
4. Neuroendocrine Tumors COEXISTS_WITH COVID-19
Subject
Neuroendocrine Tumors
Predicate
COEXISTS_WITH
Object
COVID-19
ABSTRACT
Neuroendocrine neoplasms (NENs) are a heterogeneous family of uncommon tumours with challenging diagnosis, clinical management and unique needs that almost always requires a multidisciplinary approach. In the absence of guidance from the scientific literature, along with the rapidly changing data available on the effect of COVID-19, we report how 12 high-volume NEN centres of expertise in 10 countries at different stages of the evolving COVID-19 global pandemic along with members of international neuroendocrine cancer patient societies have suggested to preserve high standards of care for patients with NENs. We review the multidisciplinary management of neuroendocrine neoplasms during the COVID-19 pandemic, and we suggest potential strategies to reduce risk and aid multidisciplinary treatment decision-making. By sharing our joint experiences, we aim to generate recommendations for proceeding to other institutions facing the same challenges.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / Thoracic Neoplasms / Carcinoid Tumor / Gastrointestinal Neoplasms / COVID-19 / Medical Oncology Type of study: Diagnostic study / Clinical Practice Guide / Prognostic study Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article Affiliation country: J.ejca.2020.11.037

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / Thoracic Neoplasms / Carcinoid Tumor / Gastrointestinal Neoplasms / COVID-19 / Medical Oncology Type of study: Diagnostic study / Clinical Practice Guide / Prognostic study Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article Affiliation country: J.ejca.2020.11.037